The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
Another 240
Bettormetrics is tracking 20+ sportsbooks throughout the World Cup, with the leaderboard updated as the tournament progresses
They work closely with your provider to ensure you have what you need
The thin outside, fat inside (TOFI) phenomenon affects a significant portion of the population, particularly as people age
Int J Mol Sci 2023;24:1703 158